Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-06-07
DOI
10.3389/fimmu.2017.00496
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia
- (2017) Ya-Zhen Qin et al. Journal of Hematology & Oncology
- Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL
- (2017) Corinna L. Boeck et al. JOURNAL OF IMMUNOTHERAPY
- Treg therapy in transplantation: a general overview
- (2017) Marco Romano et al. TRANSPLANT INTERNATIONAL
- Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
- (2016) J R Passweg et al. BONE MARROW TRANSPLANTATION
- Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets
- (2016) Marieke Griffioen et al. Frontiers in Immunology
- Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
- (2015) Aleksandar Radujkovic et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Enhanced Cytotoxic Function of Natural Killer and CD3+CD56+ Cells in Cord Blood after Culture
- (2015) Suzanne L. Tomchuck et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation
- (2015) Z Jedlickova et al. BONE MARROW TRANSPLANTATION
- Panobinostat for the Treatment of Multiple Myeloma
- (2015) J. P. Laubach et al. CLINICAL CANCER RESEARCH
- Differential activation of cord blood and peripheral blood natural killer cells by cytokines
- (2015) Rehab Alnabhan et al. CYTOTHERAPY
- Cord blood: a promising source of allogeneic natural killer cells for immunotherapy
- (2015) Hila Shaim et al. CYTOTHERAPY
- Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease
- (2015) Anke Theil et al. CYTOTHERAPY
- Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies
- (2015) Gianfranco Pittari et al. Frontiers in Immunology
- Antibody-modified T cells: CARs take the front seat for hematologic malignancies
- (2014) M. V. Maus et al. BLOOD
- CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
- (2014) M. K. Gleason et al. BLOOD
- HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
- (2014) M. F. Martelli et al. BLOOD
- DLI after haploidentical BMT with post-transplant CY
- (2014) A Ghiso et al. BONE MARROW TRANSPLANTATION
- Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21
- (2014) Bo Jiang et al. CELLULAR IMMUNOLOGY
- Extracellular Adenosine-Mediated Modulation of Regulatory T Cells
- (2014) Akio Ohta et al. Frontiers in Immunology
- Attack of the T-cell clones
- (2013) K. S. Peggs BLOOD
- HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion
- (2013) S. Stevanovi et al. BLOOD
- Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL
- (2013) M Eefting et al. BONE MARROW TRANSPLANTATION
- Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin’s lymphoma
- (2013) A Raiola et al. BONE MARROW TRANSPLANTATION
- Molecular mechanisms of natural killer cell activation in response to cellular stress
- (2013) C J Chan et al. CELL DEATH AND DIFFERENTIATION
- Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy
- (2013) Y. Liu et al. CLINICAL CANCER RESEARCH
- Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
- (2013) A. Wiernik et al. CLINICAL CANCER RESEARCH
- Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and a
- (2013) Chen-Hua Yan et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- CD4+ and CD8+T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT
- (2013) Brigitte Steger et al. IMMUNOBIOLOGY
- Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
- (2013) T Schroeder et al. LEUKEMIA
- CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
- (2013) J Chu et al. LEUKEMIA
- Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
- (2013) David A. Knorr et al. Stem Cells Translational Medicine
- Priming of PRAME- and WT1-specific CD8+T cells in healthy donors but not in AML patients in complete remission
- (2013) Willemijn van den Ancker et al. OncoImmunology
- Outcome of Donor Lymphocyte Infusion after T Cell–depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes
- (2012) Pramila Krishnamurthy et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- High Alloreactivity of Low-Dose Prophylactic Donor Lymphocyte Infusion in Patients with Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation with an Alemtuzumab-Containing Conditioning Regimen
- (2012) Maria Liga et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7
- (2012) S. S. Somanchi et al. BLOOD
- Has MRD monitoring superseded other prognostic factors in adult ALL?
- (2012) M. Bruggemann et al. BLOOD
- A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
- (2012) D. M. Benson et al. BLOOD
- Mutated regions of nucleophosmin 1 elicit both CD4+ and CD8+ T-cell responses in patients with acute myeloid leukemia
- (2012) J. Greiner et al. BLOOD
- In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping
- (2012) Susanne Reuther et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia
- (2012) R M Stone et al. LEUKEMIA
- High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses
- (2012) S K Metzelder et al. LEUKEMIA
- Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
- (2012) M. K. Gleason et al. MOLECULAR CANCER THERAPEUTICS
- Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
- (2012) Elena Provasi et al. NATURE MEDICINE
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Minor Histocompatibility Antigen UTY as Target for Graft-versus-Leukemia and Graft-versus-Haematopoiesis in the Canine Model
- (2012) D. Bund et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Natural killer cell lines in tumor immunotherapy
- (2012) Min Cheng et al. Frontiers of Medicine
- Conflicting Impact of Alloreactive NK Cells on Transplantation Outcomes after Haploidentical Transplantation: Do the Reconstitution Kinetics of Natural Killer Cells Create These Differences?
- (2011) Xiang-Yu Zhao et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
- (2011) C. Schmid et al. BLOOD
- Induction of graft versus malignancy effect after unrelated allogeneic PBSCT using donor lymphocyte infusions derived from frozen aliquots of the original graft
- (2011) J Hasskarl et al. BONE MARROW TRANSPLANTATION
- Regulatory T cells in stem cell transplantation: strategies and first clinical experiences
- (2011) Matthias Edinger et al. CURRENT OPINION IN IMMUNOLOGY
- Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia
- (2011) Marie Bleakley et al. IMMUNOLOGY AND CELL BIOLOGY
- Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells
- (2011) J Tanaka et al. LEUKEMIA
- Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
- (2011) Srinivas S. Somanchi et al. Jove-Journal of Visualized Experiments
- Decreased Infections in Recipients of Unrelated Donor Hematopoietic Cell Transplantation from Donors with an Activating KIR Genotype
- (2010) Marcie Tomblyn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Donor KIR Genes 2DL5A, 2DS1 and 3DS1 Are Associated with a Reduced Rate of Leukemia Relapse After HLA-Identical Sibling Stem Cell Transplantation for Acute Myeloid Leukemia but Not Other Hematologic Malignancies
- (2010) Kate Stringaris et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation
- (2010) J. M. Venstrom et al. BLOOD
- Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
- (2010) A. Moosmann et al. BLOOD
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
- (2010) C. G. Brunstein et al. BLOOD
- Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation
- (2010) L. Moretta et al. BLOOD
- Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia
- (2010) Xiao Chen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Biology and clinical effects of natural killer cells in allogeneic transplantation
- (2010) Jonathan E Benjamin et al. CURRENT OPINION IN ONCOLOGY
- T-Cell–Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma
- (2010) Kirsty J. Thomson et al. JOURNAL OF CLINICAL ONCOLOGY
- Complete molecular response in CML after p210 BCR–ABL1-derived peptide vaccination
- (2010) Monica Bocchia et al. Nature Reviews Clinical Oncology
- Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation
- (2010) Zeynep Arzu Yegin et al. TRANSFUSION AND APHERESIS SCIENCE
- What Is the Role for Donor Natural Killer Cells after Nonmyeloablative Conditioning?
- (2009) Frédéric Baron et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity
- (2009) A. N. Stumpf et al. BLOOD
- Management of relapse after allo-SCT for AML and the role of second transplantation
- (2009) B N Savani et al. BONE MARROW TRANSPLANTATION
- Evidence for anti-tumour effect of allogeneic haematopoietic SCT in cases without sustained donor engraftment
- (2009) E Daguindau et al. BONE MARROW TRANSPLANTATION
- Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT
- (2009) Y Chalandon et al. BONE MARROW TRANSPLANTATION
- First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells
- (2009) Piotr Trzonkowski et al. CLINICAL IMMUNOLOGY
- Cutting Edge: Bortezomib-Treated Tumors Sensitized to NK Cell Apoptosis Paradoxically Acquire Resistance to Antigen-Specific T Cells
- (2009) A. Lundqvist et al. JOURNAL OF IMMUNOLOGY
- KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia
- (2009) R Willemze et al. LEUKEMIA
- Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma
- (2008) Lauri M. Burroughs et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia
- (2008) K. Rezvani et al. BLOOD
- Graft-versus-leukemia effects of transplantation and donor lymphocytes
- (2008) H.-J. Kolb BLOOD
- CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
- (2008) A. Bashey et al. BLOOD
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML
- (2008) C F Craddock BONE MARROW TRANSPLANTATION
- Understanding and harnessing the graft-versus-leukaemia effect
- (2008) A. John Barrett BRITISH JOURNAL OF HAEMATOLOGY
- Role of KIRs and KIR ligands in hematopoietic transplantation
- (2008) Andrea Velardi CURRENT OPINION IN IMMUNOLOGY
- Quantitative assessment ofWT1gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia
- (2008) Anna Candoni et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome
- (2008) A. John Barrett et al. SEMINARS IN HEMATOLOGY
- Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia in First or Subsequent Remission: Weighing Prognostic Markers Predicting Relapse and Risk Factors for Non-relapse Mortality
- (2008) Ellen Meijer et al. SEMINARS IN ONCOLOGY
- Acute Myeloid Leukemia in the Elderly
- (2008) Hervé Dombret et al. SEMINARS IN ONCOLOGY
- WT1-specific T cell receptor gene therapy: Improving TCR function in transduced T cells
- (2007) Hans J. Stauss et al. BLOOD CELLS MOLECULES AND DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now